Showing codes S3601 (Emergency stat laboratory charge for patient who is homebound or residing in a nursing facility) — S3842 (Genetic testing for von hippel-lindau disease)

S3601 - Stat lab home/nf
Long description: Emergency stat laboratory charge for patient who is homebound or residing in a nursing facility
Code added date: 20020101.
Code effective date: 20020101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3620 - Newborn metabolic screening
Long description: Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)
Code added date: 20010101.
Code effective date: 20010701.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

S3625 - Maternal triple screen test
Long description: Maternal serum triple marker screen including alpha-fetoprotein (afp), estriol, and human chorionic gonadotropin (hcg)
Code added date: 20030701.
Code effective date: 20140101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3626 - Maternal serum quad screen
Long description: Maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a
Code added date: 20051001.
Code effective date: 20140101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3630 - Eosinophil blood count
Long description: Eosinophil count, blood, direct
Code added date: 20020101.
Code effective date: 20020101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3645 - Hiv-1 antibody testing of or
Long description: Hiv-1 antibody testing of oral mucosal transudate
Code added date: 20000101.
Code effective date: 20000101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3650 - Saliva test, hormone level;
Long description: Saliva test, hormone level; during menopause
Code added date: 20000101.
Code effective date: 20000101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3652 - Saliva test, hormone level;
Long description: Saliva test, hormone level; to assess preterm labor risk
Code added date: 20000101.
Code effective date: 20000101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3655 - Antisperm antibodies test
Long description: Antisperm antibodies test (immunobead)
Code added date: 20021001.
Code effective date: 20021001.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3708 - Gastrointestinal fat absorpt
Long description: Gastrointestinal fat absorption study
Code added date: 20010101.
Code effective date: 20010101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3711 - Circulating tumor cell test
Long description: Circulating tumor cell test
Code added date: 20090101.
Code effective date: 20120401.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3713 - Kras mutation analysis
Long description: Kras mutation analysis testing
Code added date: 20091001.
Code effective date: 20120401.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3721 - Pca3 testing
Long description: Prostate cancer antigen 3 (pca3) testing
Code added date: 20120401.
Code effective date: 20160101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3722 - Dose optimization auc - 5fu
Long description: Dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil
Code added date: 20120101.
Code effective date: 20120101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3800 - Genetic testing als
Long description: Genetic testing for amyotrophic lateral sclerosis (als)
Code added date: 20070701.
Code effective date: 20070701.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3818 - Brca1 gene anal
Long description: Complete gene sequence analysis; brca1 gene
Code added date: 20010701.
Code effective date: 20120401.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3819 - Brca2 gene anal
Long description: Complete gene sequence analysis; brca2 gene
Code added date: 20010701.
Code effective date: 20120401.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3820 - Comp brca1/brca2
Long description: Complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer
Code added date: 20030401.
Code effective date: 20120401.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3822 - Sing mutation brst/ovar
Long description: Single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer
Code added date: 20030401.
Code effective date: 20120401.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3823 - 3 mutation brst/ovar
Long description: Three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals
Code added date: 20030401.
Code effective date: 20120401.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3828 - Comp mlh1 gene
Long description: Complete gene sequence analysis; mlh1 gene
Code added date: 20030401.
Code effective date: 20120401.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3829 - Comp msh2 gene
Long description: Complete gene sequence analysis; msh2 gene
Code added date: 20030401.
Code effective date: 20120401.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3830 - Gene test hnpcc comp
Long description: Complete mlh1 and msh2 gene sequence analysis for hereditary nonpolyposis colorectal cancer (hnpcc) genetic testing
Code added date: 20020101.
Code effective date: 20120401.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3831 - Gene test hnpcc single
Long description: Single-mutation analysis (in individual with a known mlh1 and msh2 mutation in the family) for hereditary nonpolyposis colorectal cancer (hnpcc) genetic testing
Code added date: 20020101.
Code effective date: 20120401.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3833 - Comp apc sequence
Long description: Complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap
Code added date: 20030401.
Code effective date: 20140101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3834 - Sing mutation apc
Long description: Single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap
Code added date: 20030401.
Code effective date: 20140101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3835 - Gene test cystic fibrosis
Long description: Complete gene sequence analysis for cystic fibrosis genetic testing
Code added date: 20020101.
Code effective date: 20120401.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3837 - Gene test hemochromato
Long description: Complete gene sequence analysis for hemochromatosis genetic testing
Code added date: 20020101.
Code effective date: 20120401.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3840 - Dna analysis ret-oncogene
Long description: Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2
Code added date: 20030701.
Code effective date: 20030701.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3841 - Gene test retinoblastoma
Long description: Genetic testing for retinoblastoma
Code added date: 20030701.
Code effective date: 20030701.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

S3842 - Gene test hippel-lindau
Long description: Genetic testing for von hippel-lindau disease
Code added date: 20030701.
Code effective date: 20030701.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF